>500 | 42/95 | 2.5 (0.9 - 6.8) | 8.5 (1.6 - 45.5) | ||
Viral load | |||||
Undetectable | 45/73 | 1 | |||
<1000 copies | 20/24 | 1.2 (0.5 - 2.5) | |||
>1000 copies | 29/69 | 1.6 (0.9 - 3.0) | |||
ARV Regimen | 0.39 | ||||
AZT… | 34/91 | 1 | |||
TDF…. | 31/65 | 1.5 (0.3 - 1.2) | |||
…LPV/r | 01/04 | 0.5 (0.1 - 5.6) | |||
Galenic Form | 0.09 | ||||
dispersible tablets | 01/09 | 1 | |||
Dry tablets | 56/130 | 6.1 (0.7 - 49.8) | |||
Dry tablets + dispersible tablets | 05/10 | 8.0 (0.7 - 90) | |||
Daily ARV dose | 0,72 | ||||
Single-dose | 30/78 | 1 | |||
Multi-dose | 35/85 | 1.1 (0.6 - 2.1) | |||
Duration on ART (years) | 0.02 | 0.02 | |||
0 - 5 | 10/37 | 1 | 1 | ||
5 - 10 | 25/62 | 1.8 (0.7 - 4.4) | 3.8 (0.9 - 17.1) | ||
>10 | 29/57 | 2.8 (1.1 - 6.8) | 8.9 (1.6 - 50.2) |